Ironwood Pharmaceuticals is a patient-focused, biopharmaceutical company on a mission to push the boundaries of the gastrointestinal (GI) field by advancing the treatment of GI diseases and redefining the standard of care for millions of patients.
“With our focus and a passionate leadership team with extensive GI experience and deep relationships within the GI community, we have an intimate understanding of the patient journey, and are making progress towards our mission every day.”
We are one of the few biopharmaceutical companies that has discovered, developed, and now commercialize a blockbuster drug, LINZESS® (linaclotide).